Antibiotic prescription patterns in the empiric therapy of severe sepsis: combination of antimicrobials with different mechanisms of action reduces mortality
Authors:
- Ana Díaz-MartínADAna Díaz-Martín
- María Luisa Martínez-GonzálezMMMaría Luisa Martínez-González
- Ricard FerrerRFRicard Ferrer
- Carlos Ortiz-LeybaCOCarlos Ortiz-Leyba
- Enrique PiacentiniEPEnrique Piacentini
- Maria Jesus Lopez-PueyoMLMaria Jesus Lopez-Pueyo
- Ignacio Martín-LoechesIgnacio Martín-Loeches
- Mitchell M LevyMLMitchell M Levy
- Antoni ArtigasAntoni Artigas
- José Garnacho-MonteroJGJosé Garnacho-Montero
- for the Edusepsis Study GroupFGfor the Edusepsis Study Group
Open Access
- 18 November 2012
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 16 (6) , 1-9
Abstract
Introduction: Although early institution of adequate antimicrobial therapy is lifesaving in sepsis patients, optimal antimicrobial strategy has not been established. Moreover, the benefit of combination therapy over monotherapy remains to be determined. Our aims are to describe patterns of empiric antimicrobial therapy in severe sepsis, assessing the impact of combination therapy, including antimicrobials with different mechanisms of action, on mortality. Methods: This is a Spanish national multicenter study, analyzing all patients admitted to ICUs who received antibiotics within the first 6 hours of diagnosis of severe sepsis or septic shock. Antibiotic-prescription patterns in community-acquired infections and nosocomial infections were analyzed separately and compared. We compared the impact on mortality of empiric antibiotic treatment, including antibiotics with different mechanisms of action, termed different-class combination therapy (DCCT), with that of monotherapy and any other combination therapy possibilities (non-DCCT). Results: We included 1,372 patients, 1,022 (74.5%) of whom had community-acquired sepsis and 350 (25.5%) of whom had nosocomial sepsis. The most frequently prescribed antibiotic agents were β-lactams (902, 65.7%) and carbapenems (345, 25.1%). DCCT was administered to 388 patients (28.3%), whereas non-DCCT was administered to 984 (71.7%). The mortality rate was significantly lower in patients administered DCCTs than in those who were administered non-DCCTs (34% versus 40%; P = 0.042). The variables independently associated with mortality were age, male sex, APACHE II score, and community origin of the infection. DCCT was a protective factor against in-hospital mortality (odds ratio (OR), 0.699; 95% confidence interval (CI), 0.522 to 0.936; P = 0.016), as was urologic focus of infection (OR, 0.241; 95% CI, 0.102 to 0.569; P = 0.001). Conclusions: β-Lactams, including carbapenems, are the most frequently prescribed antibiotics in empiric therapy in patients with severe sepsis and septic shock. Administering a combination of antimicrobials with different mechanisms of action is associated with decreased mortality.Keywords
This publication has 32 references indexed in Scilit:
- Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis*Critical Care Medicine, 2010
- Effectiveness of Treatments for Severe Sepsis: A Prospective, Multicenter, Observational StudyAmerican Journal of Respiratory and Critical Care Medicine, 2009
- β-Lactam and Fluoroquinolone Combination Antibiotic Therapy for Bacteremia Caused by Gram-Negative BacilliAntimicrobial Agents and Chemotherapy, 2009
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008Intensive Care Medicine, 2007
- Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy*Critical Care Medicine, 2007
- Sepsis incidence and outcome: Contrasting the intensive care unit with the hospital ward*Critical Care Medicine, 2007
- The Controversy of Combination vs Monotherapy in the Treatment of Hospitalized Community-Acquired PneumoniaChest, 2005
- Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis*Critical Care Medicine, 2003
- Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort studyIntensive Care Medicine, 2001
- Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of careCritical Care Medicine, 2001